A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion
Clinical trial NCT06672523 · RECRUITING
Trial details
- NCT number
- NCT06672523
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-24
- Primary completion
- 2027-10-25
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.